{"id":52970,"date":"2025-08-01T17:03:09","date_gmt":"2025-08-01T17:03:09","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/52970\/"},"modified":"2025-08-01T17:03:09","modified_gmt":"2025-08-01T17:03:09","slug":"large-and-small-scale-bioprocessing-market-size-expected-to-hit-usd-248-12-billion-by-2034","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/52970\/","title":{"rendered":"Large And Small-scale Bioprocessing Market Size Expected to Hit USD 248.12 Billion by 2034"},"content":{"rendered":"

<\/p>\n

According to Nova One Advisor, the global large
\nand small-scale bioprocessing market size<\/a> is calculated at USD 80.75
\nbillion in 2024, grows to USD 90.34 billion in 2025, and is projected to reach
\naround USD 248.12 billion by 2034, growing at a CAGR of 11.88% from 2025 to
\n2034.<\/p>\n

<\/p>\n

The large
\nand small-scale bioprocessing<\/a> market is expanding because this
\nbioprocessing is significant to manufacturing progressive biotherapies and
\nproducts for public use. Bioprocess
\nprovides<\/a> many advantages, from vaccines, cell therapies, and biofuels
\nto food. Due to its consequences and potential outcomes, bioprocessing has
\nbecome one of the main fields of biotechnology<\/a>
\nin the world. <\/p>\n

Small-scale bioprocessing use in food
\nproduction, waste
\nmanagement<\/a>, research and development, and other applications includes
\nbiofuel production, biosensors, and single-use systems, while large-scale
\nbioprocessing use is in vaccine production, biopharmaceutical manufacturing,
\nindustrial fermentation, Stem Cell therapies, renewable energy sources, and
\nother applications.<\/p>\n

The Complete Study is Now Available for
\nImmediate Access | Download the Sample Pages of this Report@ https:\/\/www.novaoneadvisor.com\/report\/sample\/9189<\/a>\n<\/p>\n

Large and Small-scale Bioprocessing
\nMarket Highlights:<\/p>\n

\u2022 North America dominated the global large
\nand small-scale bioprocessing market, accounting for the largest share in 2024.\n<\/p>\n

\u2022 Asia Pacific is expected to show the
\nfastest growth in the market over the forecast period. <\/p>\n

\u2022 By scale, the industrial scale segment
\ndominated the market with the largest revenue share in 2024.<\/p>\n

\u2022 By scale, the small-scale segment is
\nexpected to show the fastest growth during the forecast period.<\/p>\n

\u2022 By workflow, the downstream processing
\nsegment accounted for the highest market share in 2024.<\/p>\n

\u2022 By workflow, the fermentation segment is
\nexpected to register strong growth in the market during the predicted
\ntimeframe. <\/p>\n

\u2022 By product, the bioreactors\/ fermenters
\nsegment held the biggest market share in 2024.<\/p>\n

\u2022 By product, the cell culture products
\nsegment is expected to register the fastest growth over the forecast period.<\/p>\n

\u2022 By application, the biopharmaceuticals
\nsegment dominated the market, generating the highest revenue share in 2024. <\/p>\n

\u2022 By application, the specialty industrial
\nchemicals segment is expected to register significant growth in the market
\nduring the predicted timeframe. <\/p>\n

\u2022 By use type, the multi-use segment
\ngenerated the highest market revenue share in 2024. <\/p>\n

\u2022 By use type, the single-use segment is
\nexpected to register significant growth during the forecast period.<\/p>\n

\u2022 By mode, the in-house segment captured
\nthe highest market share in 2024. <\/p>\n

\u2022 By mode, the outsourced segment is
\nexpected to grow at a significant CAGR over the forecast period.<\/p>\n

Market Overview and Industry Potential<\/p>\n

The large and small-scale bioprocessing
\nmarket is expanding due to bioprocessing is the creation of valuable products
\nthrough the use of a living thing, frequently cells or cell components,
\nviruses, or an entire organism. Finish products, anything from biofuels
\nproduced from algae, or antibiotics formed from mold, like penicillin.
\nBioprocessing hardware integrates an extensive range of gear for specific
\ncapacities and applications. The stages of bioprocessing comprise media
\npreparation, selection of biocatalyst and its optimisation, volume production,
\ndownstream processing, and purification.<\/p>\n

How are Recent Advancements in
\nBioprocessing Promoting the Growth of the Market?<\/p>\n

Recent advancements in automated
\nbioprocessing offer many advantages to the biopharmaceutical sector, including
\nbetter process control, improved product quality, lower variability, augmented
\nthroughput and effectiveness, and cost savings. The application of automation
\nin bioprocessing has revolutionized the industry, enabled real-time control of
\nthe manufacturing process and improved product quality. <\/p>\n

This results in enhanced process control
\nand optimization, lowering the challenges of deviations and enhancing product
\nquality. Automation platforms offer a comprehensive solution for electronic reports
\nand audit trails, offering upstream (USP) or downstream bioprocessing (DSP)
\nprocess engineers increasing access to process automation and data analysis,
\nwhich drives the growth of the market. <\/p>\n

What are Latest Trends of the Market<\/p>\n

\u2b25\ufe0e In February 2025, Union Budget 2025
\ncatalyses next-generation startups with novel funds. BIRAC welcomes the
\ngovernment\u2019s visionary move to expand the Fund of Funds (FFS) to Rs 20,000
\ncrore. This initiative significantly improves access to capital for startups,
\ndriving revolution and entrepreneurship across different sectors, including
\nbiotechnology.<\/p>\n

\u2b25\ufe0e In August 2024, the Department of
\nBiotechnology (DBT) launched the BioE3 Policy aimed at advancing
\nhigh-performance biomanufacturing. This initiative focuses on innovation
\nthrough integrated research and scale-up support, bridging the gap between
\ndiscovery and commercialization. Key components of the program include
\nBio-Foundry, Bio-Enabler Hubs such as Bio-Artificial Intelligence Hubs for
\ninnovation and Biomanufacturing Hubs for scaling operations.<\/p>\n

Growing Trends of Outsourcing: Market\u2019s
\nLargest Potential<\/p>\n

The increasing trend of outsourcing
\nbiomanufacturing processes is gaining traction. Biopharmaceutical companies are
\nadvancing the expertise of contract development and manufacturing organizations
\n(CDMOs) to modernize production, lowering expenses, and increasing quality.
\nThis shift is reforming the inexpensive landscape of the large and small-scale
\nbioprocessing market. <\/p>\n

Outsourcing enables a business enterprise to
\nfocus on the actions that are more significant to it. Worldwide outsourcing
\nallows for to location of freelancers or contractors from a global pool with
\nmore dedicated skills and abilities than can be found domestically.<\/p>\n

\u2b25\ufe0e For Instance, In May 2025, BioMarin
\nPharmaceutical Inc. and Inozyme Pharma, Inc. announced that BioMarin has
\nentered into a definitive agreement to acquire Inozyme for $4.00 per share in
\nan all-cash transaction for a total consideration of approximately $270
\nmillion. The transaction has been unanimously approved by the Boards of
\nDirectors of both companies and is expected to close in the third quarter of
\n2025, subject to regulatory approval, successful completion of a tender offer,
\nand other customary closing conditions.<\/p>\n

Buy Now Full Report: https:\/\/www.novaoneadvisor.com\/report\/checkout\/9189<\/a>\n<\/p>\n

Report Scope of Large And Small-scale
\nBioprocessing Market<\/p>\n

Report Coverage<\/p>\n

Details<\/p>\n

Market Size in 2025<\/p>\n

USD 90.34 Billion<\/p>\n

Market Size by 2034<\/p>\n

USD 248.12 Billion<\/p>\n

Growth Rate From 2025
\n to 2034<\/p>\n

CAGR of 11.88%<\/p>\n

Base Year<\/p>\n

2024<\/p>\n

Forecast Period<\/p>\n

2025-2034<\/p>\n

Segments Covered<\/p>\n

Scale, Workflow,
\n Product, Application, Use Type, Mode, Region<\/p>\n

Market Analysis
\n (Terms Used)<\/p>\n

Value (US$ Million\/Billion)
\n or (Volume\/Units)<\/p>\n

Regional scope<\/p>\n

North America;
\n Europe; Asia Pacific; Latin America; MEA<\/p>\n

Key Companies
\n Profiled<\/p>\n

Avantor, Inc,
\n Bio-Process Group, Bio-Synthesis, Inc., BPC Instruments AB, CESCO
\n BIOENGINEERING CO., LTD, CerCell A\/S, Corning Inc., Danaher (Cytiva), Distek,
\n Inc., Entegris, Eppendorf AG,ExcellGene SA, F. Hoffmann-La Roche Ltd, Getinge
\n AB, KUHNER AG, Lonza, Meissner Filtration Products, Inc., Merck KGaA, PBS
\n Biotech, Inc., Repligen Corporation, Saint-Gobain, Sartorius AG, Thermo
\n Fisher Scientific, Inc., Univercells Technologies<\/p>\n

Large and Small-scale Bioprocessing
\nMarket Segmentation Analysis:<\/p>\n

By Scale Analysis:<\/p>\n

The industrial scale segment dominates in
\nthe cell
\nand gene therapy<\/a> contract research organization market, as
\nbioprocessing lowers the carbon footprint of production and helps reduce
\npollution. This allows for high-yield production. The applications of
\nmicroorganisms in bioprocessing mean that large quantities of products can be
\nproduced in a limited period. This is due to microorganisms reproducing
\nquickly, permitting the production of large quantities of product in a short
\nperiod.<\/p>\n

On the other hand, the small-scale segment is
\nexpected to grow significantly during the forecast period, as it lowers the
\nexpenses is another key advantage attracting bioprocessing industries to
\nsingle-use solutions. Compared to outdated equipment, single-use solutions are
\ncheaper and simpler to install, lowering initial capital investment. This
\nbioprocessing system surges the productivity of manufacturing processes as a
\nresult of reducing expenses and complexity of automation and removal of the
\nrequirement for changeover cleaning\/validation between consecutive operations.<\/p>\n

By Workflow Analysis:<\/p>\n

The downstream
\nprocessing<\/a> segment dominated the market in 2024, as this processing
\ncomprises the separation and purification by means of centrifugation,
\nchromatography, and filtration of the cells generated throughout the downstream
\nbioprocessing step. Downstream processing often regulates the economic
\nprobability of the procedure. The first operation is cell separation, which is
\ndone through cross-flow microfiltration.<\/p>\n

On the other hand, the fermentation segment
\nis expected to grow at the fastest CAGR in the market during the forecast
\nperiod, as it provides an accurate and controlled environment for the growth of
\nmicroorganisms that are used to manufacture food ingredients such as vinegar,
\ncasein, yeast, and other fermented dairy and protein products, or ice cream.
\nThe manufacturing of sources of substitute plant-based, protein animal protein
\nalternatives for plant-based foods, additions, and alternative egg white and
\nmeat products is also possible using this process. <\/p>\n

By Product Analysis:<\/p>\n

The bioreactors\/ fermenters segment dominated
\nthe market in 2024, as it allows large-scale cultivation with close-fitting
\nenvironmental control, enhancing yields and consistency. They bridge the gap
\nfrom lab bench to manufacturing production by making conditions that are
\nproblematic to attain in basic shake flasks or petri dishes. Bioreactors offer
\na closed, sterile system, lowering contamination challenges and enabling cells
\nto be grown for longer periods or to advanced densities than in open cultures.<\/p>\n

On the other hand, the cell culture
\nproducts segment is expected to grow at the fastest CAGR in the market during
\nthe forecast period, as cell culture is one of the significant tools used in
\ncellular and molecular biology, offering excellent model systems for reviewing
\nthe usual physiology and biochemistry of cells, the effects of medicines and
\npoisonous compounds on the cells, and mutagenesis and carcinogenesis. It is
\nalso used in drug screening and development, and large-scale manufacturing of
\nbiological compounds.<\/p>\n

By Application Analysis:<\/p>\n

The biopharmaceuticals<\/a>
\nsegment dominated the market in 2024, as this process is a quickly developing
\nlandscape that is reforming the way biopharmaceuticals are produced, promising
\nenhanced efficiency, reduced expenses, and faster approval for life-saving
\nmedicines. Bioprocessing plays a significant role in the advancement and
\nproduction of advanced pharmaceuticals, with vaccines, monoclonal antibodies,
\nand gene therapies providing safer and more efficient treatments for a broad
\nrange of diseases.<\/p>\n

On the other hand, the specialty industrial
\nchemicals segment is expected to grow at the fastest CAGR in the market during
\nthe forecast period, as bioprocesses need mild reaction conditions, are more
\nspecific and efficient, and produce renewable by-products. The advancement of
\nrecombinant DNA
\ntechnology<\/a> has prolonged and extended the potential of bioprocesses.<\/p>\n

By Use-Type Analysis:<\/p>\n

The multi-use segment generated the highest
\nmarket revenue share in 2024, as the use of recyclable equipment in
\nbiopharmaceutical engineering. These procedures include equipment such as
\nstainless-steel bioreactors and media preparation systems that are cleaned and
\nsterilized between batches to produce different products, providing advantages
\nin scalability and cost-effectiveness. <\/p>\n

On the other hand, the single-use segment
\nis expected to grow at the fastest CAGR in the market during the forecast
\nperiod, extensive adoption of single-use bioprocessing technologies. The
\nadvantages include reduced challenges of cross-contamination, improved
\nflexibility in scaling production, and faster setup times. The rise in demand
\nfor single-use systems (SUS) and devices is transforming the production of
\nvaccines and biologics.<\/p>\n

By Mode Analysis:<\/p>\n

The in-house segment generated the highest
\nmarket revenue share in 2024, as this manufacturing allows to do product
\ndevelopment to be done as rapidly and as economically as possible because
\nconsumers have control over it. Thus, in-house strategies can be serious for
\nCGT entrants and drug developers that intend to become an entirely integrated
\norganization.<\/p>\n

\"A<\/p>\n

On the other hand, the outsourced segment
\nis expected to grow at the fastest CAGR in the market during the forecast
\nperiod, as outsourcing processes are emerging as an opportunity for businesses
\nto optimize their operations, lower costs, and improve overall efficiency.<\/p>\n

By Regional Insights<\/p>\n

Which Region Dominated the Large and
\nSmall-scale Bioprocessing Market in 2024?<\/p>\n

North America dominated the large and
\nsmall-scale bioprocessing market in 2024, due to the growing application of AI
\nand machine learning in bioprocessing is enhancing process optimization,
\nprognostic maintenance, and quality control. These technologies are allowing
\nmore intelligent and adaptive manufacturing processes, hypothetically leading
\nto noteworthy improvements in efficacy and product quality.<\/p>\n

\"A<\/p>\n

The US strategies for regulating
\nbiotechnology vary from those characteristically embraced in the region. North
\nAmerica with an estimated 2,840 to 6,653 active firms, which is increasing
\ndemand for the bioprocessing market.<\/p>\n

\u2b25\ufe0e For Instance, In April 2025,
\nBioProcess360 Partners announced the formation of ChromaGenix, a new
\nbiotechnology company focused on advancing downstream purification technologies
\nfor emerging biotherapeutics. The company has been formed through the transfer
\nof intellectual property, core assets, and scientific personnel from LigaTrap
\nTechnologies, LLC, a platform technology company originally spun out of North
\nCarolina State University (NC State).<\/p>\n

In the United States, there were 2,435
\nbiotechnologies in the US businesses as of 2024, a rise of 3.0% from 2023.
\nCalifornia and Massachusetts are hubs for the most biotech firms in the US,
\nwhich drives the growth of the market.<\/p>\n

Why Asia Pacific is the Fastest Growing
\nin the Large and Small-scale Bioprocessing Market?<\/p>\n

In Asia Pacific, increasing government
\nsupport for biotechnology R&D, rising demand for biologics, and rising
\napplications of biotech in personalized medicine, particularly in the
\nhealthcare sector. Growing private funding and increasing government grants in
\nthe region support biotech companies in adapting to technological advancements,
\nwhich contributes to the growth of the market.<\/p>\n

\u2b25\ufe0e For Instance, In July 2025, Asahi
\nKasei Life Science, a division of diversified global manufacturer Asahi Kasei,
\nannounced plans to construct a new spinning plant for its Planova virus removal
\nfilters in Nobeoka City, Miyazaki, Japan. The new facility will be the
\ncompany\u2019s fourth spinning plant for hollow-fiber cellulose membrane filters.<\/p>\n

Large and Small-scale Bioprocessing
\nMarket Companies:<\/p>\n

\u2022 Avantor, Inc<\/a><\/p>\n

\u2022 Bio-Process
\nGroup<\/a><\/p>\n

\u2022 Bio-Synthesis, Inc.<\/p>\n

\u2022 BPC
\nInstruments AB<\/a><\/p>\n

\u2022 CESCO BIOENGINEERING CO., LTD<\/p>\n

\u2022 CerCell A\/S<\/p>\n

\u2022 Corning Inc.<\/p>\n

\u2022 Danaher (Cytiva)<\/p>\n

\u2022 Distek,
\nInc.<\/a><\/p>\n

\u2022 Entegris<\/p>\n

\u2022 Eppendorf AG<\/p>\n

\u2022 ExcellGene SA<\/p>\n

\u2022 F. Hoffmann-La Roche Ltd<\/p>\n

\u2022 Getinge AB<\/p>\n

\u2022 KUHNER AG<\/p>\n

\u2022 Lonza<\/a><\/p>\n

\u2022 Meissner Filtration Products, Inc.<\/p>\n

\u2022 Merck KGaA<\/p>\n

\u2022 PBS Biotech, Inc.<\/p>\n

\u2022 Repligen Corporation<\/p>\n

\u2022 Saint-Gobain<\/p>\n

\u2022 Sartorius AG<\/p>\n

\u2022 Thermo Fisher Scientific, Inc.<\/p>\n

\u2022 Univercells Technologies<\/p>\n

What is Going Around the Globe?<\/p>\n

\u2b25\ufe0e In May 2025, DuPont expanded its
\nbioprocessing portfolio with the launch of DuPont AmberChrom TQ1 chromatography
\nresin for the purification of oligonucleotides and peptides in support of a
\nwide range of biopharma applications.<\/p>\n

\u2b25\ufe0e In June 2025, Ecolab Life Sciences
\nlaunched its novel Purolite AP+50 affinity chromatography resin at the
\nBiotechnology Innovation Organization (BIO) International Convention. The new
\nresin can optimize operations during the antibody manufacturing process.<\/p>\n

\u2b25\ufe0e In January 2025, Repligen Corporation<\/a>, a life
\nsciences company focused on bioprocessing technology leadership, announced the
\ncommercial launch of its CTech SoloVPE PLUS System, the most advanced UV-based
\nVariable Pathlength Technology system now available to biopharmaceutical
\nmanufacturers. The SoloVPE PLUS System is engineered to offer unparalleled
\naccuracy, speed, and ease-of-use for at-line ultraviolet-visible (UV-Vis)
\nconcentration measurement in complex biological production workflows, from
\nprocess development scale through cGMP manufacturing.<\/p>\n

\u2b25\ufe0e In April 2025, Culture
\nBiosciences<\/a>, headquartered in South San Francisco, Calif., announced
\nthe launch of Stratyx 250, which the company said in a press release is the
\nfirst mobile, cloud-integrated bioreactor that is designed to provide biotech
\ncompanies with simultaneous flexibility, automation, and remote process
\ncontrol.<\/p>\n

You can place an order or ask any
\nquestions, please feel free to contact at\u00a0sales@novaoneadvisor.com<\/a> \u00a0|
\n+1 804 441 9344<\/p>\n

Related Report <\/p>\n

\u2b25\ufe0e U.S. Large And Small-scale Bioprocessing Market – https:\/\/www.novaoneadvisor.com\/report\/us-large-and-small-scale-bioprocessing-market<\/a>\n<\/p>\n

\u2b25\ufe0e U.S. Single-use Bioprocessing Market – https:\/\/www.novaoneadvisor.com\/report\/us-single-use-bioprocessing-market<\/a>\n<\/p>\n

\u2b25\ufe0e Single-use Bioprocessing Market – https:\/\/www.novaoneadvisor.com\/report\/single-use-bioprocessing-market<\/a>\n<\/p>\n

\u2b25\ufe0e India Single-use Bioprocessing Probes And Sensors Market – https:\/\/www.novaoneadvisor.com\/report\/india-single-use-bioprocessing-probes-and-sensors-market<\/a>\n<\/p>\n

\u2b25\ufe0e Single-use Bioprocessing Probes & Sensors Market – https:\/\/www.novaoneadvisor.com\/report\/single-use-bioprocessing-probes-sensors-market<\/a>\n<\/p>\n

\u2b25\ufe0e Single-use Bioprocessing Probes And Sensors Market – https:\/\/www.novaoneadvisor.com\/report\/single-use-bioprocessing-probes-and-sensors-market<\/a>\n<\/p>\n

Segments Covered in the Report<\/p>\n

This report forecasts revenue growth at
\ncountry levels and provides an analysis of the latest industry trends in each
\nof the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc.
\nhas segmented the large and small-scale bioprocessing market.<\/p>\n

By Scale<\/p>\n

\u2022 Industrial Scale (Over 50,000 Litres)<\/p>\n

\u2022 Small Scale (Less Than 50,000 Litres)<\/p>\n

By Workflow<\/p>\n

\u2022 Downstream Processing<\/p>\n

\u2022 Fermentation<\/p>\n

\u2022 Upstream Processing<\/p>\n

By Product<\/p>\n

\u2022 Bioreactors\/Fermenters<\/p>\n

\u2022 Cell Culture Products<\/p>\n

\u2022 Filtration Assemblies<\/p>\n

\u2022 Bioreactors Accessories<\/p>\n

\u2022 Bags & Containers<\/p>\n

\u2022 Others<\/p>\n

By Application<\/p>\n

\u2022 Biopharmaceuticals<\/p>\n

\u2022 Speciality Industrial Chemicals<\/p>\n

\u2022 Environmental Aids<\/p>\n

By Use Type<\/p>\n

\u2022 Multi-Use<\/p>\n

\u2022 Single-Use<\/p>\n

By Mode<\/p>\n

\u2022 In-house<\/p>\n

\u2022 Outsourced<\/p>\n

By Regional<\/p>\n

\u2022 North America<\/p>\n

\u2022 Europe<\/p>\n

\u2022 Asia Pacific<\/p>\n

\u2022 Latin America<\/p>\n

\u2022 Middle East and Africa (MEA)<\/p>\n

Immediate Delivery Available | Buy This
\nPremium Research https:\/\/www.novaoneadvisor.com\/report\/checkout\/9189<\/a>\n<\/p>\n

About-Us<\/p>\n

Nova One Advisor is a global leader
\nin market intelligence and strategic consulting, committed to delivering deep,
\ndata-driven insights that power innovation and transformation across
\nindustries. With a sharp focus on the evolving landscape of life sciences, we
\nspecialize in navigating the complexities of cell and gene therapy, drug
\ndevelopment, and the oncology market, enabling our clients to lead in some of
\nthe most revolutionary and high-impact areas of healthcare.<\/p>\n

Our expertise spans the entire
\nbiotech and pharmaceutical value chain, empowering startups, global
\nenterprises, investors, and research institutions that are pioneering the next
\ngeneration of therapies in regenerative medicine, oncology, and precision
\nmedicine. <\/p>\n

Web: https:\/\/www.novaoneadvisor.com\/<\/a><\/p>\n

Contact Us<\/p>\n

USA:\u00a0+1 804 420 9370<\/p>\n

Email: sales@novaoneadvisor.com<\/a><\/p>\n

For Latest Update
\nFollow Us: LinkedIn<\/a><\/p><\/p>\n","protected":false},"excerpt":{"rendered":"According to Nova One Advisor, the global large and small-scale bioprocessing market size is calculated at USD 80.75…\n","protected":false},"author":2,"featured_media":52971,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[37],"tags":[28,112],"class_list":{"0":"post-52970","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-markets","8":"tag-business","9":"tag-markets"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/52970","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=52970"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/52970\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/52971"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=52970"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=52970"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=52970"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}